Fueling an epidemic, report four :  inside the Insys strategy for boosting fentanyl sales / 
 Inside the Insys strategy for boosting fentanyl sales 
U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member's Office. 
 - 1 online resource (35, [159] pages) :  color illustrations 
<br/><br/> At head of title: HSGAC minority staff report.  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>Insys Therapeutics, Inc.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Fentanyl--United States.<br/>Opioid abuse--United States.<br/>Fentanyl--Overdose--United States.<br/>Drugs--Marketing.--United States<br/>Pharmaceutical industry--Corrupt practices--United States.
<br/><br/><label>GPO Item No.: </label>1037-D (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.G 74/9:F 36